Cargando…
Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series
BACKGROUND: Bone is the most common organ of involvement in patients with Langerhans cell histiocytosis (LCH), which is often painful and associated with significant morbidity from pathological fractures. Current first-line treatments include chemotherapy and steroids that are effective but often as...
Autores principales: | Chellapandian, Deepak, Makras, Polyzois, Kaltsas, Gregory, van den Bos, Cor, Naccache, Lamia, Rampal, Raajit, Carret, Anne-Sophie, Weitzman, Sheila, Egeler, R. Maarten, Abla, Oussama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928520/ https://www.ncbi.nlm.nih.gov/pubmed/27413525 http://dx.doi.org/10.4084/MJHID.2016.033 |
Ejemplares similares
-
Bone metabolism in Langerhans cell histiocytosis
por: Anastasilakis, Athanasios D, et al.
Publicado: (2018) -
Adult Langerhans Cell Histiocytosis and the Skeleton
por: Georgakopoulou, Danae, et al.
Publicado: (2022) -
The presence of CXCR4(+) CD1a(+) cells at onset of Langerhans cell histiocytosis is associated with a less favorable outcome
por: Quispel, Willemijn T., et al.
Publicado: (2015) -
Expression and Clinical Correlation of PD-1/PD-L1 and VE1(BRAFp.V600E) in Pediatric Langerhans Cell Histiocytosis
por: Tandon, Sneha, et al.
Publicado: (2023) -
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study
por: Kemps, Paul G., et al.
Publicado: (2022)